GO:0048302 regulation of isotype switching to IgG isotypes: Immune Regulation, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0048302 describes any process that modulates the frequency, rate or extent of isotype switching to IgG isotypes, a key step in humoral immunity.
Isotype switching to IgG requires activation-induced cytidine deaminase (AID), class switch recombination, and appropriate T-cell help, especially from T follicular helper cells.
Cytokines such as IL-4 and IL-21 differentially regulate human naive B cell switching to IgG and IgA, with IL-21 promoting IgG and IgA and IL-4 modulating this response.
Dysregulated IgG isotype switching contributes to immunodeficiency with hyper-IgM, autoimmunity, and cancer-related immunosuppressive IgG4 responses.
Genetic background strongly influences antibody responsiveness and IgG isotype switching after immunization, as shown in BALB/c substrains.
CRISPR-based knockout, knock-in, and overexpression models enable causal testing of genes that regulate IgG isotype switching in B cells.

Description

Regulation of isotype switching to IgG isotypes (GO:0048302) is a biological process that controls the frequency, rate, or extent of class switch recombination to IgG subclasses. This process is central to humoral immunity because IgG antibodies mediate neutralization, opsonization, and complement activation, and their subclass distribution influences clinical outcomes in infection, autoimmunity, and transplantation. The QuickGO definition captures any modulatory input, including cytokines, transcription factors, and B-cell receptor signals, that alters the efficiency of switching to IgG. Researchers study GO:0048302 to understand how B cells integrate extrinsic and intrinsic cues to produce protective versus pathogenic IgG responses. Because IgG subclasses differ in effector function, the regulation of switching to IgG isotypes has direct implications for vaccine design, antibody therapeutics, and transplantation tolerance. Experimental models in mice and humans have revealed that T follicular helper cells, IL-21, IL-4, and genetic background each tune the magnitude and quality of IgG switching. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0048302, its molecular players, disease links, and CRISPR-based methods for functional dissection.

regulation of isotype switching to IgG isotypes At A Glance

GO ID GO:0048302
GO term regulation of isotype switching to IgG isotypes
Ontology biological_process
Synonym regulation of class switching to IgG isotypes; regulation of class switch recombination to IgG isotypes; regulation of isotype switch recombination to IgG isotypes
Definition Any process that modulates the frequency, rate or extent of isotype switching to IgG isotypes.
Major function Controls the efficiency and subclass choice of class switch recombination to IgG in activated B cells.
Key regulators IL-4, IL-21, T follicular helper cells, AID, and genetic background.
Clinical relevance Linked to hyper-IgM immunodeficiency, transplantation outcomes, and tumor-associated IgG4 responses.

What Is GO:0048302?

GO:0048302, regulation of isotype switching to IgG isotypes, is defined by QuickGO as any process that modulates the frequency, rate or extent of isotype switching to IgG isotypes. In practice, this includes signals that promote or suppress class switch recombination to IgG subclasses, such as cytokine cues, B-cell receptor engagement, and transcriptional control of the immunoglobulin heavy chain locus. The term is a biological process and is synonymous with regulation of class switching to IgG isotypes, regulation of class switch recombination to IgG isotypes, and regulation of isotype switch recombination to IgG isotypes.

Why Is regulation of isotype switching to IgG isotypes Important in Cell Biology?

GO:0048302 is important because IgG isotype switching determines the quality of antibody-mediated immunity, and its dysregulation underlies immunodeficiency, autoimmunity, and cancer progression. The regulation of switching to IgG isotypes influences vaccine efficacy, transplantation rejection, and tumor immune evasion, making it a high-value target for mechanistic and therapeutic research.
IgG subclasses differ in effector function, so regulation of switching to IgG isotypes shapes neutralization, opsonization, and complement activation.
Defective regulation of IgG switching causes hyper-IgM immunodeficiency, where patients fail to produce IgG and IgA.
T follicular helper cells regulate IgE and IgG responses, and their dysfunction alters isotype switching in allergic and autoimmune disease.
IL-21 and IL-4 differentially regulate human naive B cell switching to IgG and IgA, providing cytokine-level control of GO:0048302.
Tumor-B-cell interactions can promote immunosuppressive IgG4 switching via IL-10 in triple negative breast cancer.
Genetic background modulates antibody responsiveness to immunization, affecting IgG isotype switching in mouse substrains.
Isotype control of B cell signaling influences activation thresholds and subsequent class switching decisions.
Understanding GO:0048302 supports rational vaccine adjuvant design and antibody engineering.
CRISPR screens can identify novel regulators of IgG switching for therapeutic targeting.
Clinical monitoring of IgG subclasses informs transplantation matching and rejection risk.

What Happens During regulation of isotype switching to IgG isotypes?

B cell activation and T follicular helper cell help
In simple terms: B cells need help from specialized T cells to start switching to IgG.
Regulation of isotype switching to IgG isotypes begins with B cell activation by antigen and cognate interaction with T follicular helper cells. T follicular helper cells provide CD40L and cytokines that modulate the frequency and extent of class switch recombination to IgG. This help is essential for germinal center reactions where switching to IgG occurs.
Cytokine signals that modulate IgG switching
In simple terms: Cytokines act like instructions that tell B cells which antibody type to make.
IL-21 induces isotype switching to IgG and IgA by human naive B cells, and this response is differentially regulated by IL-4. The balance of IL-21 and IL-4 therefore modulates the rate and extent of switching to IgG isotypes, illustrating cytokine-level regulation of GO:0048302. Other cytokines may also influence this process, but IL-21 and IL-4 are well-documented regulators in human B cells.
Class switch recombination and AID activity
In simple terms: The B cell cuts and pastes its antibody gene to produce IgG.
Class switch recombination is the DNA rearrangement that replaces the IgM constant region with an IgG constant region. Activation-induced cytidine deaminase (AID) initiates this process, and its activity is required for switching to IgG isotypes. Regulation of GO:0048302 therefore includes any process that modulates AID expression, targeting, or repair of switch regions.
Isotype control of B cell signaling
In simple terms: The B cell receptor type can change how the cell responds to signals.
Isotype control of B cell signaling refers to how the immunoglobulin isotype expressed on the B cell surface influences signaling thresholds and subsequent activation. This feedback can modulate the likelihood of switching to IgG isotypes, adding a layer of regulation to GO:0048302.
Genetic and environmental modulation
In simple terms: Genes and environment fine-tune how much IgG a mouse or person makes.
Genetic regulation of antibody responsiveness to immunization differs between BALB/c substrains, demonstrating that host genetics modulate IgG isotype switching. Environmental factors such as antigen dose and adjuvant also influence the extent of switching, but genetic background is a key determinant of GO:0048302.

Key Genes Involved in GO:0048302 regulation of isotype switching to IgG isotypes

The following genes and proteins are central to the regulation of isotype switching to IgG isotypes, based on verified literature.
GeneMajor RoleResearch Relevance
AICDAInitiates class switch recombination by deaminating cytidine in switch regionsKnockout causes hyper-IgM syndrome; target for studying AID-dependent IgG switching
CD40LGProvides CD40L signal from T cells to B cells for switchingDefects cause hyper-IgM immunodeficiency; models of T-B collaboration
IL21Induces isotype switching to IgG and IgA in human naive B cellsCytokine modulation of GO:0048302; therapeutic target
IL4Differentially regulates IL-21-induced switching to IgG and IgADetermines IgG subclass bias; allergy and autoimmunity research
IL10Upregulated in tumor-B-cell interactions promoting IgG4 switchingImmunosuppressive IgG4 response in triple negative breast cancer
CD40B cell receptor for CD40L; delivers switching signalsEssential for germinal center and IgG switching
BCL6Transcriptional repressor required for T follicular helper cell differentiationRegulates Tfh help for IgG switching
STAT3Transduces IL-21 signals in B cellsLoss-of-function impairs IL-21-induced IgG switching
STAT6Transduces IL-4 signalsModulates IL-4 effects on IgG switching
PRDM1Transcriptional repressor controlling plasma cell differentiationInfluences post-switch B cell fate
XBP1Transcription factor for plasma cell differentiationDownstream of IgG switching
IGHG1Constant region gene for IgG1Target of class switch recombination; subclass analysis
IGHG2Constant region gene for IgG2Subclass-specific regulation
IGHG3Constant region gene for IgG3Subclass-specific regulation
IGHG4Constant region gene for IgG4Immunosuppressive IgG4 in cancer
TNFRSF13BTACI, regulates B cell survival and switchingModulates B cell signaling and isotype control
MS4A1CD20, B cell markerTarget for B cell depletion in autoimmunity
CR2CD21, complement receptor on B cellsModulates B cell activation thresholds

How Is regulation of isotype switching to IgG isotypes Regulated?

Regulation of isotype switching to IgG isotypes is controlled by cytokine signals, T follicular helper cell help, and B cell receptor signaling. IL-21 induces switching to IgG and IgA in human naive B cells, and IL-4 differentially regulates this response. T follicular helper cells provide CD40L and cytokines that modulate the frequency and extent of switching to IgG. Isotype control of B cell signaling further tunes activation thresholds that influence switching decisions. Genetic background also modulates antibody responsiveness to immunization, as shown in BALB/c substrains. Together, these layers of regulation determine the efficiency and subclass distribution of IgG responses.

regulation of isotype switching to IgG isotypes and Human Disease

GeneDisease / BiologyPotential Experimental Model
CD40LGHyper-IgM immunodeficiencyKnockout mouse or human B cell line with CD40LG deficiency
AICDAHyper-IgM syndrome with defective class switchingAICDA knockout B cells; knock-in of patient mutations
IL10Immunosuppressive IgG4 switching in triple negative breast cancerCoculture of B cells with tumor cells; IL10 overexpression
IL21Modulation of IgG and IgA switchingIL21 knockout or overexpression in human naive B cells
IL4Differential regulation of IgG switchingIL4 knockout or receptor blockade in B cell cultures
Hyper-IgM immunodeficiency
Immunodeficiency with hyper-IgM (HIM) is characterized by defective class switch recombination, leading to low IgG and IgA and elevated IgM. Mutations in genes required for switching, such as CD40LG and AICDA, cause HIM, demonstrating that disruption of GO:0048302 underlies this disease.
Transplantation and IgG subclasses
The biology of IgG subclasses is clinically relevant to transplantation, where IgG subclass profiles influence rejection and graft survival. Regulation of switching to IgG isotypes therefore affects alloimmune responses and transplant outcomes.
Cancer and immunosuppressive IgG4
Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers. This links dysregulated GO:0048302 to tumor immune evasion and suggests targeting IgG4 switching as a therapeutic strategy.
Allergy and T follicular helper cell regulation
T follicular helper cells regulate IgE and also influence IgG responses, and their dysfunction can alter isotype switching in allergic disease. Understanding how Tfh cells modulate GO:0048302 may inform therapies for allergy and autoimmunity.

From regulation of isotype switching to IgG isotypes-Related Genes to Experimental Models

Research QuestionSuitable Model
Does gene X regulate IgG isotype switching?CRISPR knockout in primary B cells or B cell lines
Does a patient mutation in AICDA impair switching?Point mutation knock-in in B cells
Can a tag be added to AID to track switch recombination?Tagged knock-in of AICDA
Does overexpression of IL-21 enhance IgG switching?Overexpression of IL21 in B cell cultures
Which genes are essential for IgG switching?CRISPR library screening in B cells
How does IL-10 from tumor cells affect IgG4 switching?Coculture with IL10 knockout tumor cells

How to Study the regulation of isotype switching to IgG isotypes Process

MethodWhat It MeasuresTypical Application
Flow cytometrySurface IgG subclass expressionQuantify switched B cells after cytokine stimulation
ELISPOTAntibody-secreting cellsAssess functional IgG switching
ELISASecreted IgG subclassesMeasure cytokine effects on IgG production
CRISPR screenGene essentiality for IgG switchingIdentify novel regulators of GO:0048302
RNA-seqTranscript levels of AICDA and IGHGTranscriptional profiling of switching
Western blotAID protein expressionConfirm AID-dependent switching
Coculture assaysTumor-B-cell interactionsModel IgG4 switching in cancer
BioinformaticsPathway enrichment of screen hitsInterpret CRISPR screen data
Flow cytometry for IgG subclass detection
Flow cytometry using antibodies against IgG subclasses measures the frequency of switched B cells after stimulation. This method is widely used to quantify regulation of isotype switching to IgG isotypes in vitro.
ELISPOT and ELISA for antibody secretion
ELISPOT and ELISA quantify IgG-secreting cells and secreted IgG subclasses, providing functional readouts of class switching. These methods are standard for assessing cytokine effects on IgG switching.
CRISPR screening and bioinformatics
CRISPR library screening combined with bioinformatics identifies genes that regulate IgG switching. This approach enables unbiased discovery of modulators of GO:0048302.
RNA-seq and transcriptomics
RNA-seq measures expression of AICDA, IGHG transcripts, and cytokine receptors during switching, revealing transcriptional programs that regulate IgG isotype switching.

How CRISPR Can Be Used to Study GO:0048302 regulation of isotype switching to IgG isotypes

Knockout

CRISPR knockout of candidate genes in B cell lines or primary B cells tests whether they are required for IgG isotype switching. For example, AICDA knockout abolishes class switch recombination, confirming its essential role in GO:0048302.

Point Mutation

Point mutation knock-in models patient-specific mutations, such as those in AICDA or CD40LG, to dissect how single amino acid changes impair IgG switching.

Knock-in

Knock-in of tagged alleles, such as AID-GFP, allows tracking of AID expression and localization during class switch recombination, providing dynamic readouts of GO:0048302.

Overexpression

Overexpression of cytokines such as IL-21 or IL-10 in B cell cultures or tumor cells tests their sufficiency to promote IgG switching, as shown for IL-21-induced switching and IL-10-driven IgG4 responses.

How EDITGENE Supports regulation of isotype switching to IgG isotypes Research

Researchers studying regulation of isotype switching to IgG isotypes-related genes often need to determine whether a candidate gene is causally involved in class switch recombination or simply correlated with B cell activation. EDITGENE provides CRISPR-based knockout, point mutation, knock-in, overexpression, and library screening services to enable such causal experiments in B cell models.
Contact EDITGENE today to design your custom CRISPR model for regulation of isotype switching to IgG isotypes research.

Frequently Asked Questions About regulation of isotype switching to IgG isotypes

GO:0048302 is the Gene Ontology term for regulation of isotype switching to IgG isotypes, defined as any process that modulates the frequency, rate or extent of isotype switching to IgG isotypes.
Key genes include AICDA, CD40LG, IL21, IL4, IL10, and immunoglobulin heavy chain constant genes such as IGHG1-4.
IL-21 induces switching to IgG and IgA in human naive B cells, and IL-4 differentially regulates this response, while IL-10 can promote IgG4 switching in tumors.
Hyper-IgM immunodeficiency, transplantation rejection, and cancer-associated immunosuppressive IgG4 responses are linked to dysregulated IgG switching.
Activation-induced cytidine deaminase (AID) initiates class switch recombination, and its activity is required for switching to IgG isotypes.
CRISPR knockout, knock-in, and overexpression models can test causal roles of genes in IgG switching, and CRISPR screens can identify novel regulators.
Flow cytometry, ELISPOT, ELISA, RNA-seq, and CRISPR screens are commonly used to measure IgG switching and identify regulators.
Yes, T follicular helper cells provide CD40L and cytokines that modulate the frequency and extent of switching to IgG isotypes.
Yes, genetic regulation of antibody responsiveness to immunization differs between BALB/c substrains, affecting IgG isotype switching.
IgG subclasses differ in effector function and are clinically relevant to transplantation, infection, and autoimmunity.

Conclusion

GO:0048302, regulation of isotype switching to IgG isotypes, is a central biological process that controls the efficiency and subclass distribution of IgG responses. Cytokines, T follicular helper cells, AID, and genetic background all modulate this process, and its dysregulation contributes to immunodeficiency, transplantation complications, and cancer immune evasion. CRISPR-based models and functional assays provide powerful tools to dissect the causal genes and pathways that regulate IgG isotype switching, supporting the development of targeted therapies and improved vaccines.

References

  1. 1. Valenzuela NM et al.. 2018. The Biology of IgG Subclasses and Their Clinical Relevance to Transplantation.. Transplantation 102(1S Suppl 1):S7-S13 PMID: 29266057
  2. 2. Gowthaman U et al.. 2020. Regulation of IgE by T follicular helper cells.. J Leukoc Biol 107(3):409-418 PMID: 31965637
  3. 3. Notarangelo LD et al.. 1992. Immunodeficiency with hyper-IgM (HIM).. Immunodefic Rev 3(2):101-21 PMID: 1554497
  4. 4. Silver K et al.. 2003. Isotype control of B cell signaling.. Sci STKE 2003(184):pe21 PMID: 12771436
  5. 5. Toney NJ et al.. 2022. Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers.. J Transl Med 20(1):112 PMID: 35255925
  6. 6. Avery DT et al.. 2008. IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4.. J Immunol 181(3):1767-79 PMID: 18641314
  7. 7. Poyntz HC et al.. 2019. Genetic regulation of antibody responsiveness to immunization in substrains of BALB/c mice.. Immunol Cell Biol 97(1):39-53 PMID: 30152893
  8. 8. Yu K et al.. 2019. Current insights into the mechanism of mammalian immunoglobulin class switch recombination.. Crit Rev Biochem Mol Biol 54(4):333-351 PMID: 31509023
Contact Us
*
*
*
*
How did you hear about us: